Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

View source ↗

Summary

Clinical trial update on the effectiveness and safety of tirzepatide for obesity with or without type 2 diabetes; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mounjaro (tirzepatide) (tirzepatide)

Snippet

Sponsor: Dr. Md. Alimur Reza | Conditions: Obesity | Status: NOT_YET_RECRUITING